EBV infection |
Ccnd2/Cd3g/Irf9/Psmd2/Ifnar2/Nfkb2/Cd3e/Nedd4/Isg15/Cdk6/H2-T22/H2-T22/H2-Q7/H2-Q7/H2-Q6 |
3.96E−04 |
Endocytosis |
Ap2a2/Rabep1/Cblb/Agap2/Smap1/Clta/Nedd4/Eea1/Rab11fip2/Sh3kbp1/Arf3/H2-T22/H2-T22/H2-Q7/H2-Q7/H2-Q6 |
3.96E−04 |
Cellular senescence |
Ccnd2/Mapkapk2/Ppp3cc/Ppp3ca/Itpr1/Eif4ebp1/Cdk6/H2-T22/H2-T22/Rbbp4/H2-Q7/H2-Q7/H2-Q6 |
3.96E−04 |
Kaposi sarcoma−associated herpesvirus infection |
Irf9/Mapkapk2/Pik3cg/Ppp3cc/Ifnar2/Ppp3ca/Itpr1/Cdk6/Gng2/H2-T22/H2-T22/H2-Q7/H2-Q7/H2-Q6 |
3.96E−04 |
HIV1 infection |
Cd3g/Apobec3/Ppp3cc/Ppp3ca/Itpr1/Cd3e/Skp1a/Gng2/H2-T22/H2-T22/Trim30d/H2-Q7/H2-Q7/H2-Q6 |
9.00E−04 |
Human CMV infection |
Gna13/Ppp3cc/Ppp3ca/Itpr1/Eif4ebp1/Ptger4/Cdk6/Gng2/ H2-T22/H2-T22/H2-Q7/H2-Q7/H2-Q6 |
6.37E−03 |
C-type lectin receptor signaling pathway |
Irf9/Mapkapk2/Ppp3cc/Cblb/Nfkb2/Casp1/Ppp3ca/Itpr1 |
1.07E−02 |
Measles |
Ccnd2/Cd3g/Irf9/Cblb/Ifnar2/Csnk2b/Ifih1/Cd3e/Cdk6 |
1.15E−02 |
Human T cell leukemia virus 1 infection |
Ccnd2/Cd3g/Ppp3cc/Nfkb2/Xiap/Ppp3ca/Cd3e/H2-T22/H2-T22/H2-Q7/H2-Q7/H2-Q6 |
1.17E−02 |
Ag processing and presentation |
Rfxap/Cd8a/H2-T22/H2-T22/H2-Q7/H2-Q7/H2-Q6 |
1.37E−02 |